InflaRx N.V.: InflaRx Assessing Feasibility of Broadened Strategy for ANCA-Associated Vasculitis in Europe Following EMA Recommendation on Tavneos

InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated vasculitis (AAV)The Company is assessing the most efficient de ...
Frontiers

Complement-targeted therapies for transplant-associated thrombotic microangiopathy: recent advances

Transplant-associated thrombotic microangiopathy (TA-TMA) is a life-threatening complication of hematopoietic stem cell transplantation in which systemic complement activation induces endothelial ...
BMJ

Clinical and cost-effectiveness of the Lightning Process in addition to specialist medical care for paediatric chronic fatigue syndrome: randomised controlled trial

Objective Investigate the effectiveness and cost-effectiveness of the Lightning Process (LP) in addition to specialist medical care (SMC) compared with SMC alone, for children with chronic fatigue ...
IEEE

Variable Latency Speculative Parallel Prefix Adders for Unsigned and Signed Operands

Abstract: A variable latency adder (VLA) reduces average addition time by using speculation: the exact arithmetic function is replaced by an approximated one, that is ...